Cargando…
Correlation of Immunohistochemistry and Fluorescence in Situ Hybridization for HER-2 Assessment in Breast Cancer Patients: Single Centre Experience
BACKGROUND: Accurate assessment of HER-2 is imperative in selecting patients for targeted therapy. Most commonly used test methods for HER-2 are immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH). We evaluated the concordance between FISH and IHC for HER-2 in breast cancer samp...
Autores principales: | Bogdanovska-Todorovska, Magdalena, Kostadinova-Kunovska, Slavica, Jovanovik, Rubens, Krsteska, Blagica, Kondov, Goran, Kondov, Borislav, Petrushevska, Gordana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927485/ https://www.ncbi.nlm.nih.gov/pubmed/29731922 http://dx.doi.org/10.3889/oamjms.2018.124 |
Ejemplares similares
-
Presentation of the Molecular Subtypes of Breast Cancer Detected By Immunohistochemistry in Surgically Treated Patients
por: Kondov, Borislav, et al.
Publicado: (2018) -
Impact of Size of the Tumour, Persistence of Estrogen Receptors, Progesterone Receptors, HER2Neu Receptors and Ki67 Values on Positivity of Axillary Lymph Nodes in Patients with Early Breast Cancer with Clinically Negative Axillary Examination
por: Kondov, Borislav, et al.
Publicado: (2017) -
Signet ring cell carcinoma of rectum metastasizing to synchronous renal cell carcinoma: a case report
por: Krsteska, Blagica, et al.
Publicado: (2021) -
Decoupling channel count from field of view and spatial resolution in single-sensor imaging systems for fluorescence image-guided surgery
por: Blair, Steven, et al.
Publicado: (2022) -
Thyroid Cancer Detection Rate and Associated Risk Factors in Patients with Thyroid Nodules Classified As Bethesda Category III
por: Mileva, Magdalena, et al.
Publicado: (2018)